395 related articles for article (PubMed ID: 32865389)
1. Nanoparticle Delivery of MnO
Chang CC; Dinh TK; Lee YA; Wang FN; Sung YC; Yu PL; Chiu SC; Shih YC; Wu CY; Huang YD; Wang J; Lu TT; Wan D; Chen Y
ACS Appl Mater Interfaces; 2020 Oct; 12(40):44407-44419. PubMed ID: 32865389
[TBL] [Abstract][Full Text] [Related]
2. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
3. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.
Song M; Liu T; Shi C; Zhang X; Chen X
ACS Nano; 2016 Jan; 10(1):633-647. PubMed ID: 26650065
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
[TBL] [Abstract][Full Text] [Related]
5. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response.
Prasad P; Gordijo CR; Abbasi AZ; Maeda A; Ip A; Rauth AM; DaCosta RS; Wu XY
ACS Nano; 2014 Apr; 8(4):3202-12. PubMed ID: 24702320
[TBL] [Abstract][Full Text] [Related]
7. Reversing Hypoxia with PLGA-Encapsulated Manganese Dioxide Nanoparticles Improves Natural Killer Cell Response to Tumor Spheroids.
Murphy DA; Cheng H; Yang T; Yan X; Adjei IM
Mol Pharm; 2021 Aug; 18(8):2935-2946. PubMed ID: 34191525
[TBL] [Abstract][Full Text] [Related]
8. Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Liu JY; Chiang T; Liu CH; Chern GG; Lin TT; Gao DY; Chen Y
Mol Ther; 2015 Nov; 23(11):1772-1782. PubMed ID: 26278330
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
11. CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
Gao DY; Lin TsT; Sung YC; Liu YC; Chiang WH; Chang CC; Liu JY; Chen Y
Biomaterials; 2015 Oct; 67():194-203. PubMed ID: 26218745
[TBL] [Abstract][Full Text] [Related]
12. A multifunctional oxygen-producing MnO
Yang C; Liu Y; Su S; Gao N; Jing J; Zhang X
J Mater Chem B; 2020 Nov; 8(43):9943-9950. PubMed ID: 33034314
[TBL] [Abstract][Full Text] [Related]
13. Albumin-MnO
Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
[TBL] [Abstract][Full Text] [Related]
14. Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment.
Lin T; Zhang Q; Yuan A; Wang B; Zhang F; Ding Y; Cao W; Chen W; Guo H
Theranostics; 2020; 10(17):7683-7696. PubMed ID: 32685013
[TBL] [Abstract][Full Text] [Related]
15. Pd@Au Bimetallic Nanoplates Decorated Mesoporous MnO
Zhang Y; Lv F; Cheng Y; Yuan Z; Yang F; Liu C; Cao Y; Zhang K; Lu H; Zada S; Guo S; Dong H; Zhang X
Adv Healthc Mater; 2020 Jan; 9(2):e1901528. PubMed ID: 31820854
[TBL] [Abstract][Full Text] [Related]
16. Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.
Shigeta K; Datta M; Hato T; Kitahara S; Chen IX; Matsui A; Kikuchi H; Mamessier E; Aoki S; Ramjiawan RR; Ochiai H; Bardeesy N; Huang P; Cobbold M; Zhu AX; Jain RK; Duda DG
Hepatology; 2020 Apr; 71(4):1247-1261. PubMed ID: 31378984
[TBL] [Abstract][Full Text] [Related]
17. Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.
Zhu P; Chen Y; Shi J
ACS Nano; 2018 Apr; 12(4):3780-3795. PubMed ID: 29613770
[TBL] [Abstract][Full Text] [Related]
18. A multifunctional cascade enzyme system for enhanced starvation/chemodynamic combination therapy against hypoxic tumors.
Xing Z; Li L; Liao T; Wang J; Guo Y; Xu Z; Yu W; Kuang Y; Li C
J Colloid Interface Sci; 2024 Jul; 666():244-258. PubMed ID: 38598997
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation.
Feng L; Xie R; Wang C; Gai S; He F; Yang D; Yang P; Lin J
ACS Nano; 2018 Nov; 12(11):11000-11012. PubMed ID: 30339353
[TBL] [Abstract][Full Text] [Related]
20. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]